SSC 20 - SSC Session - Fibrinolysis

Speaker(s)

• 

  Paul Kim, PhD

  Associate Professor
  Department of Medicine, McMaster University
  Hamilton, Ontario, Canada
• 

  Alisa Wolberg, PhD

  Professor
  Pathology and Laboratory Medicine
  Univerisity of North Carolina at Chapel Hill
  Chapel Hill, North Carolina, United States

Presentations:

• 4:30 PM – 4:40 PM

  Introduction
  

  Speaker: Tetsumei Urano, MD, PhD – Shizuoka Graduate University of Public Health
• 4:40 PM – 5:05 PM

  Clinical Relevance of Fibrinolysis Phenotypes
  

  Speaker: Ernest E Moore, MD – Ernest E Moore Shock Trauma Center atDenver Health
• 5:05 PM – 5:20 PM

  Contrasting Fibrinolysis Profiles by Euglobulin Clot Lysis Time (ECLT) in Two Patient Populations with Bleeding Phenotypes: Trauma and Hypoproliferative Thrombocytopenia”
  

  Speaker: Anton Ilich, MD – Division of Hematology and Blood Research Center, University of North Carolina, Chapel Hill
• 5:20 PM – 5:40 PM

  Measurement of Plasmin Generation Potential in Clinical Samples
  

  Speaker: Alisa S. Wolberg, PhD – Univerisity of North Carolina at Chapel Hill
• 5:40 PM – 5:45 PM

  Q&A
  

  Speaker: Tetsumei Urano, MD, PhD – Shizuoka Graduate University of Public Health
• 5:45 PM – 6:00 PM

  The Relationship Between Perioperative Changes of Fibrinolysis and Graft Function During Liver Transplantation
  

  Speaker: Hunter B. Moore, MD – Division of Transplant Surgery, University of Colorado School of Medicine
• 6:00 PM – 6:10 PM

  Standardization of Assays of Soluble Thrombomodulin Antigen and Activity in Plasma: Project Proposal
  

  Speaker: Michael B. Boffa, PhD – Western University, Robarts Research Institute
• 6:10 PM – 6:20 PM

  The Proposed WHO 1st International Standard for Thrombin-Activatable Fibrinolysis Inhibitor (TAFI), Plasma
  

  Speaker: Craig Thelwell, PhD – National Institute for Biological Standards and Control (NIBSC)
• 6:20 PM – 6:25 PM

  Q&A
  

  Speaker: Tetsumei Urano, MD, PhD – Shizuoka Graduate University of Public Health
• 6:25 PM – 6:30 PM

  Conclusion
  

  Speaker: Tetsumei Urano, MD, PhD – Shizuoka Graduate University of Public Health